Table 1.
Study group characteristics of men diagnosed with prostate cancer during pre-screening and screening period (A) and of screened and not-screened persons (B).
| A | Pre-Screening (1998–2005) | Screening (2006–2016) |
|---|---|---|
| Patients diagnosed with prostate cancer (%) (N 1) | 11,401 | 37,418 |
| Median age at prostate cancer diagnosis (IQR 2), years. | 72 (66; 77) | 67 (61; 73) |
| Mean follow-up time (IQR), days. | 2076 (613; 4222) | 1728 (859; 2802) |
| Number of deaths (%) | 8782 (77.03) | 11,079 (29.61) |
| B | Not-Screened | Screened |
| Patients diagnosed with prostate cancer (%) (N 1) | 5886 | 31,532 |
| Median age at prostate cancer diagnosis (IQR 2), years. | 78 (73; 82) | 66 (60; 71) |
| Mean follow-up time (IQR), days. | 1093 (261; 2377) | 1811 (983; 2852) |
| Number of deaths (%) | 3805 (64.64) | 7274 (23.06) |
1 Number; 2 IQR—interquartile range.